The Cancer Microbiome Market has gained significant attention due to the rising prevalence of chronic cancers worldwide. In 2025, the market size was valued at USD 320.30 Million, and it is projected to grow at a CAGR of 19.90% between 2026 and 2035, reaching USD 1966.75 Million by the end of the forecast period. Researchers and healthcare providers are increasingly recognizing the role of the microbiome in cancer development and treatment, which is fueling demand for microbiome-based diagnostics and therapies.

Cancer Microbiome Market Size, Share, and Trend

The Cancer Microbiome Market size is expanding as technological advancements enable precise profiling of gut, oral, and tumor-associated microbiomes. Market trends indicate a growing investment in R&D for microbiome-based therapeutics, personalized medicine, and non-invasive diagnostic tools. North America currently dominates the market in terms of share due to advanced healthcare infrastructure and increased awareness, followed by Europe and Asia Pacific, which are emerging markets due to rising cancer cases and growing healthcare expenditure.

Market Breakup by Type

The Cancer Microbiome Market is categorized into:

Products – Includes microbiome profiling kits, sequencing tools, and diagnostic assays.

Services – Comprises microbiome analysis, bioinformatics services, and consulting.

Market Breakup by End User

The key end users of the Cancer Microbiome Market include:

Hospitals – Utilizing microbiome diagnostics for personalized cancer treatment.

Diagnostic Labs – Offering specialized microbiome testing and analysis.

Market Breakup by Region

North America – Leading in market share with advanced research initiatives.

Europe – Growth driven by government funding and clinical trials.

Asia Pacific – Rapidly expanding due to rising cancer incidence.

Latin America – Increasing awareness and healthcare adoption.

Middle East and Africa – Emerging market opportunities with growing medical infrastructure.

Request sample report Explore

Key Companies in the Cancer Microbiome Market

Major players contributing to market growth include Novogene Corporation, Psomagen, PerkinElmer Genomics, Illumina, Thermo Fisher Scientific, Viome, Invivo Healthcare, Zymo Research Corp, Metabiomics, and CD Genomics. These companies focus on innovations in microbiome sequencing, diagnostics, and therapeutics.